Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 228

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 228
---
 Selling Stockholder on July 23, 2024.                               
 Represents  Exchange                                                                                                                 
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                           
 Represents Exchange                                                                                                                  
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                           |
|:---|:-------------------------------------------------------------------------------------------------------------------------------------|
| 29 | Represents Exchange                                                                                                                  
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                           |
| 30 | Consists of 416,997                                                                                                                  
 shares of Common Stock and 35,538 Exchange Shares issued to the Selling Stockholder on July 23, 2024.                                |
| 31 | Represents  Exchange                                                                                                                 
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                           |
| 32 | Represents  Exchange                                                                                                                 
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                           |
| 33 | Consists of 792,545                                                                                                                  
 shares of Common Stock and 323,070 Exchange Shares issued to the Selling Stockholder on July 23, 2024.                               |
| 34 | Represents Exchange                                                                                                                  
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                           |
| 35 | Represents Exchange                                                                                                                  
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                           |
| 36 | Represents Exchange                                                                                                                  
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                           |
| 37 | Represents Exchange                                                                                                                  
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                           |

Material Relationships with Selling Stockholders.

Other than as disclosed above, none of the Selling
Stockholders has had a material relationship with us or any of our affiliates other than as a stockholder at any time within the past
three years.

<div align='center'>Alt-5

[RESALE PROSPECTUS ALTERNATE PAGE]

USE OF PROCEEDS</div>

All shares of our Common
Stock offered by this Resale Prospectus are being registered for the account of the Selling Stockholders identified herein. We will not
receive any of the proceeds from the sale of these shares.

We will receive proceeds
from any cash exercise of the Investor Warrants, which, if exercised in cash with respect to all of the 6,372,265 shares of common stock
underlying the Investor Warrants, would result